SNCAIP, (which inhibits ubiquitin ligase activity), connects with PTN (Fig. 6F; a hub gene encoding for a protein having a role in cell survival, angiogenesis and tumorigenesis), previously noted to be elevated in MM patients [38]. Here, PTN is linked to Miyoshi myopathy.